Loading company…
Won 3 federal SBIR/STTR research awards from HHS and other federal agencies.
GLYCOPATH INC has been awarded 3 US Small Business Innovation Research (SBIR/STTR) contracts totalling $926,895 between 2019 and 2023. These are non-dilutive federal research grants, not equity financing. The company is based in CHARLESTON, South Carolina.
No investors recorded yet for GLYCOPATH INC.
Add an investorGLYCOPATH INC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for GLYCOPATH INC.
Add diversity data